Close Menu

NEW YORK — Israeli diagnostics firm Ibex Medical Analytics said on Thursday that it has received CE-IVD marking for its artificial intelligence-based prostate cancer detection system.

Called Galen Prostate, the system is designed to help pathologists detect and grade prostate cancer in biopsies. It uses an algorithm the company said was trained on slides from a dataset of over 60,000 prostate slides from multiple institutions and representing a variety of diagnoses and clinical findings.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.